← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2013Last known activity
Dec 1, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 4 trials)
Phase 4 (4 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT05615987Overall official - principal investigatorPhase 4Dec 1, 2022
- NCT05615987Reponsible party - principal investigatorPhase 4Dec 1, 2022
- NCT05615987Lead sponsorPhase 4Dec 1, 2022
- NCT04443556Lead sponsorN/AAug 31, 2020
- NCT04443556Reponsible party - principal investigatorN/AAug 31, 2020
- NCT04290104Lead sponsorPhase 4Mar 1, 2020
- NCT04290104Reponsible party - principal investigatorPhase 4Mar 1, 2020
- NCT02576340Reponsible party - principal investigatorPhase 4Jan 1, 2013
- NCT02576340Lead sponsorPhase 4Jan 1, 2013
Details
- Last known activity
- Dec 1, 2022